MYXOFIBROSARCOMA
Clinical trials for MYXOFIBROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new MYXOFIBROSARCOMA trials appear
Sign up with your email to follow new studies for MYXOFIBROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for young sarcoma patients: trial tests aggressive drug combo
Disease control Recruiting nowThis study is testing a combination of chemotherapy drugs (ifosfamide, doxorubicin), a targeted drug (pazopanib), and sometimes a newer drug (selinexor) and radiation therapy for young patients (up to age 30) with rare soft tissue cancers. The goal is to see if this approach can …
Matched conditions: MYXOFIBROSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Proton beam trial aims to zap inoperable tumors with higher, safer doses
Disease control Recruiting nowThis study is testing whether a newer type of radiation therapy, called proton beam therapy, can be given at a higher dose to better control inoperable soft tissue sarcomas. The goal is to see if this approach stops tumor growth for at least two years without increasing side effe…
Matched conditions: MYXOFIBROSARCOMA
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
Targeted attack: new combo therapy fights tough limb cancers
Disease control Recruiting nowThis study is testing whether a new combination treatment can safely slow the growth of advanced sarcoma tumors in an arm or leg. It combines a targeted limb chemotherapy procedure with a drug that helps the immune system fight cancer. The goal is to see if this approach can keep…
Matched conditions: MYXOFIBROSARCOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC